Christopher Taylor, MD
Colon & Rectal Surgery · Colorado Springs, CONPI 1669834487
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,178 of the $16,241 with a category attached, or 87.3%. Intuitive Surgical accounts for 98.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $8,697 and has fallen 99.3% since, to $58 in 2025.
Across 37 payments — averaging $438.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$16K
- Myriad Genetic Laboratories, Inc.$79
- Integra Lifesciences Corporation$63
- Medtronic$61
- Takeda Pharmaceuticals U.S.A., Inc.$31
- Solventum Corporation$31
- plus $57 from 3 others
What the payments were for
- Travel & lodging$3972%
- Food & beverage$1,63110%
- Education$14,17887%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 25 | $15,919 |
| Myriad Genetic Laboratories, Inc. | 2 | $79 |
| Integra Lifesciences Corporation | 2 | $63 |
| Medtronic | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Solventum Corporation | 1 | $31 |
| Boston Scientific | 1 | $24 |
| Johnson & Johnson | 1 | $17 |
| Innovation Technologies Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$14,000
- Da Vinci Surgical System$1,324
How this compares
$16,241 in reported general payments places this provider in the 85th percentile of 24 colon & rectal surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 19 | $1,990 |
| Neomycin Sulfate | 64 | $270 |
| Oxycodone Hcl | 70 | $256 |
| Cyclobenzaprine Hcl | 52 | $141 |
| Ondansetron Hcl | 45 | $133 |
| Metronidazole | 62 | $92 |
| Potassium Chloride | 50 | $91 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $84 |
| Klor-Con M20Potassium Chloride | 16 | $18 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Colorado Springs
- Garrett ShackletonColorado Springs$4K
- Eben StrobosLakewood$1.3M
- David LongcopeDenver$425K
- Daine BennettEnglewood$28K
- Warren StruttDenver$16K
- Michael McNevinAurora$14K
- Jon VogelAurora$14K
- Brandon ChapmanAurora$12K
- Douglas BensonLone Tree$10K
- Santosh NandiEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.